Paper10692746
Oral gastrografin in neonates: a note of caution.
Tuladhar R and 3 others. Int J Clin Pract, 1999. Cited by 16 papers, by iCite.
Cite this record
ConductScience Library. Oral gastrografin in neonates: a note of caution. Papers, record 10692746. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/10692746
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Bacteremia | Major topic |
| Contrast Media | Major topic |
| Diatrizoate Meglumine | Major topic |
| Enterocolitis, Necrotizing | Major topic |
| Iodides | Major topic |
| Fatal Outcome | |
| Female | |
| Gram-Negative Bacterial Infections | |
| Humans | |
| Infant | |
| Infant, Newborn | |
| Osmolar Concentration |
Source PubMed
Cited by8
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 16 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41458695 | Evaluating the Safety of Gastrointestinal Contrast Agents in Pediatric Patients: A Retrospective Study. | Cureus | 2025 | https://conductscience.org/library/papers/41458695 | PubMed |
| 34936086 | Interventions for treating distal intestinal obstruction syndrome (DIOS) in cystic fibrosis. | Cochrane Database Syst Rev | 2021 | https://conductscience.org/library/papers/34936086 | PubMed |
| 34936085 | Interventions for preventing distal intestinal obstruction syndrome (DIOS) in cystic fibrosis. | Cochrane Database Syst Rev | 2021 | https://conductscience.org/library/papers/34936085 | PubMed |
| 33498880 | Optimizing Nutritional Strategies to Prevent Necrotizing Enterocolitis and Growth Failure after Bowel Resection. | Nutrients | 2021 | https://conductscience.org/library/papers/33498880 | PubMed |
| 30075058 | Interventions for treating distal intestinal obstruction syndrome (DIOS) in cystic fibrosis. | Cochrane Database Syst Rev | 2018 | https://conductscience.org/library/papers/30075058 | PubMed |
| 29894558 | Interventions for preventing distal intestinal obstruction syndrome (DIOS) in cystic fibrosis. | Cochrane Database Syst Rev | 2018 | https://conductscience.org/library/papers/29894558 | PubMed |
| 26918125 | Necrotizing enterocolitis: controversies and challenges. | F1000Res | 2015 | https://conductscience.org/library/papers/26918125 | PubMed |
| 16632657 | Not all osmolality is created equal. | Arch Dis Child Fetal Neonatal Ed | 2006 | https://conductscience.org/library/papers/16632657 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/10692746
GET https://conductscience.org/api/papers/v1/10692746/authors